Aron E. Kefela, MD joined the cancer care team of Northwest Georgia Oncology Centers, P.C. (NGOC) in August 2014. Dr. Kefela treats all forms of cancer and blood disorders with a special interest in breast cancer. He completed his Fellowship in Hematology and Medical Oncology at Allegheny Health Network, Temple University in Pittsburgh, PA in June 2014 and completed his Internship and Residency in Internal Medicine at St. Vincent Hospital in Indianapolis, IN in 2009. Dr. Kefela received his Doctorate of Medicine from Indiana University School of Medicine in Indianapolis, IN.
He is actively involved in cancer research and clinical trials to find a cancer cure and provide patients with the most advanced cancer treatment available in Georgia.
Dr. Kefela provides patient-centered cancer care at NGOC’s Paulding Cancer Center and Douglasville Cancer Center.
| Personal Data | Birthplace: Asmara, Eritrea |
| Undergraduate Education | Oakland Community College Farmington Hills, MI May 1997 Wayne State University Detroit, MI May 2000 Indiana University, School of Medicine Indianapolis, IN May 2002 |
| Medical Education | Doctor of Medicine Indiana University, School of Medicine Indianapolis, IN May 2006 |
| Postdoctoral Training | INTERNSHIP Internal Medicine St. Vincent Hospital Indianapolis, IN July 2006 - June 2007 RESIDENCY Internal Medicine St. Vincent Hospital Indianapolis, IN July 2007- June 2009 FELLOWSHIP Hematology & Medical Oncology Allegheny Health Network, Temple University Pittsburgh, PA July 2011 – June 2014 |
| Board Certification | American Board of Internal Medicine, Internal Medicine, 2010 American Board of Internal Medicine, Medical Oncology, 2014 American Board of Internal Medicine, Hematology, 2017 |
| Medical Licensure | State of Georgia, 2014 |
| Professional Societies | American Society of Clinical Oncology American Society of Hematology National Cancer Institute |
| Honors | Department of Clinical Laboratory Science Scholarship, 1999 Dean's List, 1996-1999 |
| Publications | ABSTRACTS Aron Kefela, Ruemu Birhiray, Syed Moazzem Accuracy of MRI vs. Mammography in the Evaluation of Patients Who Received Neoadjuvant Treatment in Minimally Invasive Breast Cancer. American Society of Breast Diseases Annual Symposium April 2010 . New York Aron Kefela, Entezam Sahovic, Jocelyn De Yao, Santosh Sadashiv, James Rossetti, Salman Fazal, Cyrus Khan, Gina Berteotti, Joh Lister Fludarabine, Intravenous Busulfan, and Total Body Irradiation (FluBUTBI) Conditioning for Allogeneic Peripheral Blood Stem Cell Transplantation the Western Pennsylvania Cancer Institute Experience American Society for Blood and Marrow Transplantation 2014 BMT Tandem Meeting February 2014 Dallas, Texas. Abstract 358 Santosh Sadashiv, Entezam Sahovic, Pritam Tayshetye, Jocelyn De Yao, Aron Kefela, James Rossetti, Salman Fazal, Cyrus Khan, Gina Berteotti, Joh Lister Reduced Intensity Fludarabine and Intravenous Busulfan (FB2) for Allogeneic Peripheral Blood Stem Cell Transplantation American Society for Blood and Marrow Transplantation 2014 BMT Tandem Meeting February 2014 Dallas, Texas. Abstract 387 |
| Research Activity | Clinical Trials (Oncology & Hematology) -Retrospective study of safety and efficacy of Flu/BU/TBI conditioning regimen in allogeneic stem cell transplantation, July 2012-March 2014. -Retrospective review of outcome of patients with early stage HER2/Neu positive breast cancer (Stage 1, T1a, T1b) who received Herceptin vs. those who did not, March 2013-June 2014. -Accuracy of MRI vs. mammography in the evaluation of patients who received neoadjuvant treatment in minimally invasive breast cancer, August 2009-December 2009. Presented poster in ASBD Annual Symposium, New York, 2010. |